Login / Signup

Clinical value of offering multiple chemotherapy lines to a luminal-like metastatic breast cancer: A case report with eribulin.

Anna Amela ValsecchiJessica PaparoValeria PirroMatteo ManfrediMassimo Di MaioRossana Dionisio
Published in: Tumori (2022)
This case report aims to emphasize the clinical value of a chronic chemotherapy treatment also in heavily pretreated and luminal-like metastatic breast cancer, supporting eribulin as a good choice to consider.
Keyphrases
  • metastatic breast cancer
  • case report
  • squamous cell carcinoma
  • clinical trial
  • randomized controlled trial
  • rectal cancer
  • replacement therapy